Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential applications. Initial findings suggest that this higher dosage may boost the drug's ability to regulate blood glucose, potentially offering more significant outcomes for individuals with type 2 diabetes. Further investigation is underway to fully expl